Literature DB >> 23826912

An 8-year survey of strains identified in blood cultures in a clinical haematology unit.

A Bousquet1, J-V Malfuson, N Sanmartin, J Konopacki, C MacNab, B Souleau, T de Revel, M Elouennass, T Samson, C Soler, V Foissaud, C Martinaud.   

Abstract

The aim of our study was to determine the epidemiological profile and the antibiotic susceptibility of bacteria and fungi identified from blood cultures in the patients of the clinical haematology unit. A retrospective study was carried out over an 8-year period (2003-2010) in the clinical haematology unit of the Percy Military Medical Center. During this period, we collected 723 isolates: Gram-negative bacilli (70.8%) and Gram-positive cocci (18.7%). The four most commonly isolated species were Escherichia coli (18.5%), Pseudomonas aeruginosa (14.8%), Stenotrophomonas maltophilia (6.2%) and Staphylococcus epidermidis (5.4%). The rate of methicillin-resistant Staphylococcus aureus was 6.45% and that of coagulase-negative staphylococci 61.2%. No resistance to glycopeptides was observed. In E. coli, as in the Klebsiella-Enterobacter-Serratia group, a 27% resistance to fluoroquinolones was observed. Concerning P. aeruginosa, the phenotypes were distributed over penicillinase (23.4%) and cephalosporinase (13.1% were resistant to ceftazidime). The impermeability rate of imipenem was 9.3%. The aggressiveness and duration of haematological treatments explains why infections remain one of the main complications of neutropenia. The emergence of new or unusual bacteria is highly likely. Antibiotic selective pressure and long periods of hospitalization could explain the emergence of multiresistant bacteria. As a consequence, epidemiological surveillance is indispensable.
© 2013 The Authors Clinical Microbiology and Infection © 2013 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Keywords:  Bacteraemia; bone marrow; haematology; infections; neutropenia; transplantation

Mesh:

Substances:

Year:  2013        PMID: 23826912     DOI: 10.1111/1469-0691.12294

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  11 in total

1.  Impact of neutropenia on the clinical outcomes of Staphylococcus aureus bacteremia in patients with hematologic malignancies: a 10-year experience in a tertiary care hospital.

Authors:  Byung-Han Ryu; Seung Cheol Lee; Minjeong Kim; Yewon Eom; Jiwon Jung; Min Jae Kim; Heungsup Sung; Mi-Na Kim; Sung-Han Kim; Sang-Oh Lee; Sang-Ho Choi; Jun Hee Woo; Yang Soo Kim; Yong Pil Chong
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-01-10       Impact factor: 3.267

2.  The Relationship between Hope and Self-Esteem in Patients with Leukemia.

Authors:  Kobra Parvan; Faranak Jabbarzadeh Tabrizi; Azad Rahmani; Morteza Ghojazadeh; Arman Azadi; Mehri Golchin
Journal:  J Caring Sci       Date:  2015-09-01

Review 3.  Rethinking Antimicrobial Prophylaxis in the Transplant Patient in the World of Emerging Resistant Organisms-Where Are We Today?

Authors:  Lucy E Horton; Nina M Haste; Randy A Taplitz
Journal:  Curr Hematol Malig Rep       Date:  2018-02       Impact factor: 3.952

4.  Quality of end-of-life care in patients with hematologic malignancies: a retrospective cohort study.

Authors:  David Hui; Neha Didwaniya; Marieberta Vidal; Seong Hoon Shin; Gary Chisholm; Joyce Roquemore; Eduardo Bruera
Journal:  Cancer       Date:  2014-02-18       Impact factor: 6.860

5.  Detailed epidemiological analysis as a strategy for evaluating the actual behavior of tuberculosis in an apparently low-incidence region.

Authors:  Ana Laura Guillén-Nepita; Gerardo Vázquez-Marrufo; Andrés Cruz-Hernández; Felipe García-Oliva; Reyna Cristina Zepeda-Gurrola; Ma Soledad Vázquez-Garcidueñas
Journal:  Pathog Glob Health       Date:  2020-09-14       Impact factor: 2.894

6.  Synthesis, characterization and antimicrobial activity of conjugates based on fluoroquinolon-type antibiotics and gelatin.

Authors:  Giuseppe Cirillo; Maria Vittoria Mauro; Umile Gianfranco Spizzirri; Paolina Cavalcanti; Francesco Puoci; Cristina Giraldi; Orazio Vittorio; Nevio Picci; Francesca Iemma
Journal:  J Mater Sci Mater Med       Date:  2013-10-09       Impact factor: 3.896

Review 7.  The prevention and management of infections due to multidrug resistant organisms in haematology patients.

Authors:  Jason A Trubiano; Leon J Worth; Karin A Thursky; Monica A Slavin
Journal:  Br J Clin Pharmacol       Date:  2015-02       Impact factor: 4.335

8.  Bloodstream infections in patients with hematological malignancies: which is more fatal - cancer or resistant pathogens?

Authors:  Habip Gedik; Funda Simşek; Arzu Kantürk; Taner Yildirmak; Deniz Arica; Demet Aydin; Naciye Demirel; Osman Yokuş
Journal:  Ther Clin Risk Manag       Date:  2014-09-17       Impact factor: 2.423

9.  The lung mycobiome: an emerging field of the human respiratory microbiome.

Authors:  Linh D N Nguyen; Eric Viscogliosi; Laurence Delhaes
Journal:  Front Microbiol       Date:  2015-02-13       Impact factor: 5.640

10.  Outbreak of Extended-Spectrum Beta-Lactamase Producing Enterobacter cloacae with High MICs of Quaternary Ammonium Compounds in a Hematology Ward Associated with Contaminated Sinks.

Authors:  Angélique Chapuis; Lucie Amoureux; Julien Bador; Arthur Gavalas; Eliane Siebor; Marie-Lorraine Chrétien; Denis Caillot; Marion Janin; Claire de Curraize; Catherine Neuwirth
Journal:  Front Microbiol       Date:  2016-07-12       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.